Catawba Research

Executive Summary

Catawba Research, founded in 1984 and headquartered in Hickory, North Carolina, is a privately held contract research organization (CRO) specializing in diagnostics and infectious disease. The company positions itself as an agile CRO delivering tailored study solutions from first clinical program to market authorization, leveraging over 160 years of leadership combined experience and a team that has executed more than 1,000 clinical trials. Catawba's 'Catawba Way' emphasizes nimble approaches, active scientific leadership, and submission-ready deliverables. While the company lacks public funding or valuation data, its longevity and niche focus on diagnostics suggest deep expertise in a growing segment, particularly post-pandemic. As a private entity, Catawba Research is not publicly traded but remains a potential partner for biotech and pharma firms seeking a responsive, experienced CRO in infectious disease and diagnostic development.

Upcoming Catalysts (preview)

• Q3 2026Securing multiple new client contracts in infectious disease diagnostics65% success
• Q4 2026Expansion of laboratory or operational capacity to support growing demand50% success
• Q2 2026Formation of strategic partnership with a diagnostic or biotech company for a pivotal trial55% success